Federal Register / Vol. 86, No. 165 / Monday, August 30, 2021 / Notices 48433 

Policy for Extramural Research 

Administration, 6705 Rockledge Drive, 

8th Floor Room 803, Bethesda, 

Maryland 20892, or call a non-toll-free 

number 301–435–0941 or Email your 

request, including your address to 

ProjectClearanceBranch@mail.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) The necessity and utility of 

the proposed information collection for 

the proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: NIH COVID–19 

Vaccine Attestation Intake Form. 

Type of Collection: Emergency. 

OMB Number: 0925–NEW. 

Abstract: The U.S. Office of Personnel 

Management (OPM) approved the U.S. 

Department of Health and Human 

Services’ (HHS) request for a variation 

to a strict application of 5 CFR 339.205 

under 5 CFR.1 to promote the efficiency 

of the Government. Under this variation, 

HHS may use the authority under 5 CFR 

339.205 to mandate COVID–19 

vaccinations authorized under 

Emergency Use Authorizations (EUA) 

for its patient-facing health care 

personnel, including its health care 

applicants and employees, who work in 

Indian Health Service (IHS) medical 

facilities, National Institutes of Health 

(NIH) clinical research facilities, or 

other HHS facilities that provide direct 

patient care or clinical research. In 

addition, the Safer Federal Workforce 

Task Force created by President Biden’s 

Executive Order 13991 has instructed 

Federal Agencies to inquire about the 

COVID–19 vaccination status of federal 

employees and on-site contractors. The 

NIH now has a COVID–19 vaccination 

requirement for persons working in 

Building 10 on the Bethesda campus, 

those with patient contact, or probable 

patient contact. The proposed 

information collection will be used to 

ensure compliance with these 

requirements, generate the list of 

persons required to be tested on a 

routine basis, and will provide 

important information regarding safety 

frameworks, guidance, and procedures. 

The purpose of the information 

collection is to promote the safety of the 

federal workplace consistent with the 

above-referenced authorities, the 

COVID–19 Workplace Safety: Agency 

Model Safety Principles established by 

the Safer Federal Workforce Task Force, 

and guidance from the Centers for 

Disease Control and Prevention (CDC) 

and the Occupational Safety and Health 

Administration (OSHA). 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of 

collection 

Number of 

respondents 

Number 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

NIH COVID–19 Vaccine Attestation intake form ............................................. 31,000 1 5/60 2,583 

Total .......................................................................................................... ........................ 31,000 ........................ 2,583 

Dated: August 24, 2021. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2021–18636 Filed 8–27–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the National Advisory 

Allergy and Infectious Diseases Council. 

The meeting will be open to the 

public. The open session will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov). 

Individuals who need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Date: September 13, 2021 

Open: 10:30 a.m. to 11:30 a.m. 

Agenda: Report of Institute Director 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4G30 

Rockville, MD 20892 (Virtual Meeting). 

Closed: 11:45 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4G30 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD, 

20892 301–496–7291, fentonm@

niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Acquired Immune Deficiency Syndrome 

Subcommittee. 

Date: September 13, 2021. 

Open 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4G30, 

Rockville, MD 20832 (Virtual Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4G30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 


khammond on DSKJM1Z7X2PROD with NOTICES
48434 Federal Register / Vol. 86, No. 165 / Monday, August 30, 2021 / Notices 

20892, 301–496–7291, fentonm@

niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Microbiology and Infectious Diseases 

Subcommittee. 

Date: September 13, 2021. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health 5601 Fishers Lane, Room 4G30, 

Rockville, MD 20892 (Virtual Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4G30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, fentonm@

niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Immunology and Transplantation 

Subcommittee. 

Date: September 13, 2021. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 

4G30Rockville, MD 20892 (Virtual Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4G30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, fentonm@

niaid.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.niaid.nih.gov/about/advisory-council, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 25, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18649 Filed 8–27–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the AIDS Research Advisory 

Committee, NIAID. 

The meeting will be open to the 

public. The open session will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov). 

Individuals who need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

Name of Committee: AIDS Research 

Advisory Committee, NIAID. 

Date: September 13, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 8D49, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Pamela Gilden, Branch 

Chief, Science Planning and Operations 

Branch, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 8D49, 

Rockville, MD 20852–9831, 301–594–9954, 

pamela.gilden@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 25, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18647 Filed 8–27–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2021–0629; Control 

Number 1625–0003] 

Information Collection Request to 

Office of Management and Budget; 

OMB 

AGENCY: Coast Guard, DHS. 

ACTION: Sixty-day notice requesting 

comments. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

U.S. Coast Guard intends to submit an 

Information Collection Request (ICR) to 

the Office of Management and Budget 

(OMB), Office of Information and 

Regulatory Affairs (OIRA), requesting 

approval of an extension for the 

following collection of information: 

1625–0003, Recreational Boating 

Accident Report; without change. 

Our ICR describes the information we 

seek to collect from the public. Before 

submitting this ICR to OIRA, the Coast 

Guard is inviting comments as 

described below. 

DATES: Comments must reach the Coast 

Guard on or before October 29, 2021. 

ADDRESSES: You may submit comments 

identified by Coast Guard docket 

number [USCG–2021–0629] to the Coast 

Guard using the Federal eRulemaking 

Portal at https://www.regulations.gov. 

See the ‘‘Public participation and 

request for comments’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

further instructions on submitting 

comments. 

A copy of the ICR is available through 

the docket on the internet at https://

www.regulations.gov. Additionally, 

copies are available from: 

COMMANDANT (CG–6P), ATTN: 

PAPERWORK REDUCTION ACT 

MANAGER, U.S. COAST GUARD, 2703 

MARTIN LUTHER KING JR. AVE. SE, 

STOP 7710, WASHINGTON, DC 20593– 

7710. 

FOR FURTHER INFORMATION CONTACT: A.L. 

Craig, Office of Privacy Management, 

telephone 202–475–3528, or fax 202– 

372–8405, for questions on these 

documents. 

SUPPLEMENTARY INFORMATION: 

Public Participation and Request for 

Comments 

This notice relies on the authority of 

the Paperwork Reduction Act of 1995; 

44 U.S.C. chapter 35, as amended. An 

ICR is an application to OIRA seeking 

the approval, extension, or renewal of a 

Coast Guard collection of information 


khammond on DSKJM1Z7X2PROD with NOTICES